Neurimmune
Manufacturing · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Wagistrasse 13, Schlieren, Zurich, 8952,...Phone Number
+41 447554646Website
www.neurimmune.comRevenue
$7.3 MillionIndustry
About Neurimmune
Is Neurimmune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Neurimmune, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Neurimmune
Funding: Get notified immidiatlly once Neurimmune has new funding data
Earning: See what the market has to say on Neurimmune recently announced quarterly report
Product Launch: Get notified when Neurimmune launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Neurimmune had a recent Job posting/layoffs
Check out if Neurimmune is spiking on competitors!
Check if Neurimmune has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Neurimmune is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neurimmune is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neurimmune.
Neurimmune Tech Stack
A closer look at the technologies used by Neurimmune
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurimmune
Neurimmune is a biopharmaceutical company focused on translating human immune memory into antibody therapeutics. Their pipeline includes drug candidates for Alzheimer's disease, amyotrophic lateral sclerosis, spinal cord injury, cardiomyopathy, and type 2 diabetes. Utilizing Reverse Translational Medicine technology, they develop therapeutic antibo... Read More